Abstract:Previous studies have investigated the lower embryo implantation rates in women with polycystic ovary syndrome, obesity and type 2 diabetes, and specifically the association between the abnormal oocyte and embryo and hyperinsulinemia. The importance of hyperinsulinemia on maternal endometrium receptivity remains to be elucidated. The present study used a hyperinsulinemic mouse model to determine whether hyperinsulinemia may affect endometrial receptivity. An insulin intervention mouse model was first established. The serum levels of insulin, progesterone and estradiol were subsequently detected by ELISA assay analysis. The number of implantation sites was recorded using Trypan blue dye and the morphology of mice uteri was investigated using hematoxylin and eosin staining. The expression levels of molecular markers associated with endometrial receptivity were detected by reverse transcription‑quantitative polymerase chain reaction, western blotting and immunohistochemistry analyses. Finally, the importance of mechanistic target of rapamycin (mTOR) expression following insulin treatment was determined. Mice treated with insulin developed insulin resistance and hyperinsulinemia. The number of implantation sites following insulin treatment did not differ between the control and insulin‑treated groups. Additionally, no significant morphological alterations in mice uteri between control and insulin‑treated groups were observed. However, the expression levels of estrogen receptor (Esr) 1, Esr2, progesterone receptor and homeobox A10 associated with endometrial receptivity, were imbalanced during endometrium receptivity when maternal hyperinsulinemia was induced. Western blot analysis revealed that expression levels of endometrial phosphorylated (p)‑mTOR and p‑ribosomal protein S6 kinase β‑1 were significantly greater in the insulin‑treated group. These results demonstrated that although an embryo may implant into endometrium, mice endometrium receptivity in early pregnancy may be impaired by maternal hyperinsulinemia. In addition, mTOR signaling may be involved in this process. The present study provides preliminary results demonstrating that female reproduction may be compromised during hyperinsulinemia, which requires further investigation in future studies.

Molecular Mechanism and Biological Effects of Endometrial Insulin Resistance in Polycystic Ovary Syndrome

Endometrial Abnormality in Women with Polycystic Ovary Syndrome

Effects of Immune Cells and Cytokines on the Endometrial Immune Microenvironment in Polycystic Ovary Syndrome

The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms

Mice Endometrium Receptivity in Early Pregnancy is Impaired by Maternal Hyperinsulinemia

Study of insulin concentration and its receptor expression on endometrium of polycystic ovary syndrome with normal level of OGTT

An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome

Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

Hyperandrogenic Milieu Dysregulates the Expression of Insulin Signaling Factors and Glucose Transporters in the Endometrium of Patients With Polycystic Ovary Syndrome

Analysis of IVF-ET outcomes in patients with polycystic ovarian syndrome with different level of Insulin resistance

Uterine Function: From Normal to Polycystic Ovarian Syndrome Alterations

Approach to the Patients with Polycystic Ovary Syndrome

Polycystic ovary syndrome and infertility: an update

Research status of polycystic ovary syndrome and endometrial hyperplasia

A Molecular and Cellular Review of the Literature

Advances in Molecular Genetic Study on PCOS

Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway

Independent and Joint Effects of Β-Cell Dysfunction and Insulin Resistance on Reproductive Outcomes of IVF Cycles in Infertile PCOS Patients

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Insulin Resistance, Polycystic Ovary Syndrome and Metformin